HCA Healthcare Inc (HCA)

HCA Healthcare executives engaged in multiple share sales throughout February 2026. Key leadership, including the CEO and various senior officers, executed these divestments between February 3 and February 18. No insider trading activity has occurred within the last three months, rendering recent market performance metrics irrelevant to these historical equity movements.
Ticker: HCA Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for HCA Healthcare Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
McAlevey Michael R EVP & Chief Legal & Admin Off. Officer
Transaction date
Sale
Price
234.90
Quantity 76,319 +14.1%
Value US$1,386,967
2.7
Michael R McAlevey OFFICER Officer
Transaction date
Proposed sale
Price
390.01
Quantity 1,851
Value US$2,613,357
2.9
Wyatt Christopher F. SVP & Controller Officer
Transaction date
Sale
Price
165.71
Quantity 91,992 +40.1%
Value US$1,728,387
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
526.16
Quantity 4,010 -25.1%
Value US$2,109,920
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
503.00
Quantity 4,010 -20.0%
Value US$2,017,030
2.7
Jennifer L. Berres OFFICER Officer
Transaction date
Proposed sale
Price
514.58
Quantity 8,020
Value US$4,126,950
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
497.18
Quantity 120 -0.4%
Value US$59,661
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
498.12
Quantity 4,293 -11.7%
Value US$2,138,442
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
498.80
Quantity 5,162 -12.3%
Value US$2,574,794
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
500.02
Quantity 6,189 -12.9%
Value US$3,094,609
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
500.69
Quantity 7,395 -13.3%
Value US$3,702,626
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
502.15
Quantity 5,002 -8.3%
Value US$2,511,757
2.5
HAZEN SAMUEL N CEO Executive Director
Transaction date
Sale
Price
502.95
Quantity 14,716 -19.6%
Value US$7,401,386
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Sale
Price
498.09
Quantity 1,500 -4.8%
Value US$747,135
2.8
MICHAEL S CUFFE OFFICER Officer
Transaction date
Proposed sale
Price
498.09
Quantity 1,500
Value US$747,135
2.5
Samuel N. Hazen President, Chief Executive Officer & Director Executive Director
Transaction date
Proposed sale
Price
501.04
Quantity 42,877
Value US$21,483,274
2.7
Michael R McAlevey OFFICER Officer
Transaction date
Proposed sale
Price
473.79
Quantity 3,892
Value US$1,843,991
2.7
McAlevey Michael R EVP & Chief Legal & Admin Off. Officer
Transaction date
Sale
Price
473.79
Quantity 3,892 -52.7%
Value US$1,843,991
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
418.84
Quantity 3,836
Value US$1,606,670
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
418.84
Quantity 3,836 -10.9%
Value US$1,606,670
2.5
Foster Jon M EVP and COO Officer
Transaction date
Sale
Price
369.32
Quantity 15,698 -55.4%
Value US$5,797,661
2.5
Foster Jon M Officer Officer
Transaction date
Proposed sale
Price
369.32
Quantity 15,698
Value US$5,797,660
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
322.31
Quantity 5,378 -25.9%
Value US$1,733,362
2.7
Berres Jennifer SVP & Chief Human Res. Officer Officer
Transaction date
Sale
Price
322.96
Quantity 4,155 -16.7%
Value US$1,341,878
2.7
Berres Jennifer Officer Officer
Transaction date
Proposed sale
Price
322.59
Quantity 9,533
Value US$3,075,238
2.5
Reiner Deborah M Former Officer Officer
Transaction date
Proposed sale
Price
322.39
Quantity 3,510
Value US$1,131,589
3.0
Whalen Kathleen M Former Officer Officer
Transaction date
Proposed sale
Price
335.26
Quantity 3,228
Value US$1,082,203
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
357.99
Quantity 1,474 -13.5%
Value US$527,677
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
357.99
Quantity 1,474
Value US$527,677
3.3
Akdamar Erol R Officer Officer
Transaction date
Proposed sale
Price
357.86
Quantity 4,872
Value US$1,743,480
Billington Phillip G Officer Officer
Transaction date
Proposed sale
Price
350.00
Quantity 3,897
Value US$1,363,950
3.3
Akdamar Erol R Group President Officer
Transaction date
Sale
Price
353.00
Quantity 2,900 -29.8%
Value US$1,023,700
Billington Phillip G SVP-Internal Audit Services Officer
Transaction date
Planned sale
Price
350.00
Quantity 3,897 -6.9%
Value US$1,363,950
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
385.42
Quantity 8,358
Value US$3,221,340
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
385.42
Quantity 8,358 -22.0%
Value US$3,221,340
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
363.51
Quantity 2,987
Value US$1,085,804
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
363.51
Quantity 2,987 -24.0%
Value US$1,085,804
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
359.92
Quantity 1,864 -13.0%
Value US$670,891
2.5
Reiner Deborah M SVP - Mktg. & Communications Officer
Transaction date
Sale
Price
359.96
Quantity 3,314 -48.6%
Value US$1,192,914
2.9
Wyatt Christopher F. Officer Officer
Transaction date
Proposed sale
Price
360.20
Quantity 4,000
Value US$1,440,783
2.5
Reiner Deborah M Officer Officer
Transaction date
Proposed sale
Price
359.96
Quantity 3,314
Value US$1,192,914
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
359.92
Quantity 1,864
Value US$670,891
2.9
Wyatt Christopher F. SVP & Controller Officer
Transaction date
Sale
Price
360.20
Quantity 4,000 -9.0%
Value US$1,440,782
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
355.05
Quantity 1,857 -9.5%
Value US$659,328
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
355.05
Quantity 1,857
Value US$659,328
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
326.30
Quantity 3,204 -25.3%
Value US$1,045,465
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
326.30
Quantity 3,204
Value US$1,045,465
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
326.18
Quantity 1,863 -8.7%
Value US$607,673
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
326.18
Quantity 1,863
Value US$607,673
1.8
Cohen Jeffrey E. SVP-Government Relations Officer
Transaction date
Sale
Price
313.00
Quantity 1,650 -24.1%
Value US$516,450
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Sale
Price
316.88
Quantity 6,311 -17.6%
Value US$1,999,825
1.8
Cohen Jeffrey E. Officer Officer
Transaction date
Proposed sale
Price
313.00
Quantity 1,650
Value US$516,450
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
316.88
Quantity 6,311
Value US$1,999,824
2.8
RUTHERFORD BILL B Former Officer Officer
Transaction date
Proposed sale
Price
311.36
Quantity 15,000
Value US$4,670,373
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
309.00
Quantity 1,600 -4.5%
Value US$494,400
2.8
Cuffe Michael S. Officer Officer
Transaction date
Proposed sale
Price
309.00
Quantity 1,600
Value US$494,400
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
312.00
Quantity 890 -4.0%
Value US$277,680
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
312.00
Quantity 973 -4.2%
Value US$303,576
3.0
Torres Kathryn A. Officer Officer
Transaction date
Proposed sale
Price
312.00
Quantity 1,863
Value US$581,256
Wasserman Chad J Officer Officer
Transaction date
Proposed sale
Price
330.25
Quantity 876
Value US$289,299
Wasserman Chad J SVP and CIO Officer
Transaction date
Planned sale
Price
330.25
Quantity 876 -35.7%
Value US$289,299
Wasserman Chad J SVP and CIO Officer
Transaction date
Planned sale
Price
321.97
Quantity 344 -12.3%
Value US$110,758
Wasserman Chad J Officer Officer
Transaction date
Proposed sale
Price
321.97
Quantity 344
Value US$110,758
3.0
Whalen Kathleen M SVP & Chief Ethics Officer Officer
Transaction date
Sale
Price
306.21
Quantity 4,262 -29.4%
Value US$1,305,074
3.0
Whalen Kathleen M Officer Officer
Transaction date
Proposed sale
Price
306.21
Quantity 4,262
Value US$1,305,074
2.8
RUTHERFORD BILL B Officer Officer
Transaction date
Proposed sale
Price
310.63
Quantity 6,000
Value US$1,863,780
2.8
RUTHERFORD BILL B CFO and EVP Officer
Transaction date
Sale
Price
310.63
Quantity 6,000 -41.5%
Value US$1,863,780
2.9
Wyatt Christopher F. SVP & Controller Officer
Transaction date
Sale
Price
312.42
Quantity 4,000 -9.7%
Value US$1,249,680
1.5
Mosier Sammie S SVP & Chief Nurse Executive Officer
Transaction date
Sale
Price
312.00
Quantity 1,645 -17.7%
Value US$513,240
2.9
Wyatt Christopher F. Officer Officer
Transaction date
Proposed sale
Price
312.42
Quantity 4,000
Value US$1,249,680
1.5
Mosier Sammie S Officer Officer
Transaction date
Proposed sale
Price
312.00
Quantity 1,645
Value US$513,240
Wasserman Chad J SVP and CIO Officer
Transaction date
Planned sale
Price
312.04
Quantity 652 -69.2%
Value US$203,451
Wasserman Chad J Officer Officer
Transaction date
Proposed sale
Price
312.04
Quantity 652
Value US$203,451
2.8
Cuffe Michael S. EVP and Chief Clinical Officer Officer
Transaction date
Planned sale
Price
306.79
Quantity 3,200 -11.4%
Value US$981,734
3.0
Torres Kathryn A. SVP-Payer Contracting & Align. Officer
Transaction date
Sale
Price
307.00
Quantity 3,861 -19.5%
Value US$1,185,327
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-18 2026-02-18 S Sale

EVP & Chief Legal & Admin Off.

Officer
76,319 +14.1%
234.90
US$1,386,967
76,319 +14.1% 234.90 US$1,386,967
2026-02-18 2026-02-18 PrS Proposed sale

OFFICER

Officer
1,851
390.01
US$2,613,357
1,851 390.01 US$2,613,357
2026-02-12 2026-02-11 S Sale

SVP & Controller

Officer
91,992 +40.1%
165.71
US$1,728,387
91,992 +40.1% 165.71 US$1,728,387
2026-02-12 2026-02-11 S Sale

SVP & Chief Human Res. Officer

Officer
4,010 -25.1%
526.16
US$2,109,920
4,010 -25.1% 526.16 US$2,109,920
2026-02-12 2026-02-11 S Sale

SVP & Chief Human Res. Officer

Officer
4,010 -20.0%
503.00
US$2,017,030
4,010 -20.0% 503.00 US$2,017,030
2026-02-11 2026-02-11 PrS Proposed sale

OFFICER

Officer
8,020
514.58
US$4,126,950
8,020 514.58 US$4,126,950
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
120 -0.4%
497.18
US$59,661
120 -0.4% 497.18 US$59,661
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
4,293 -11.7%
498.12
US$2,138,442
4,293 -11.7% 498.12 US$2,138,442
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
5,162 -12.3%
498.80
US$2,574,794
5,162 -12.3% 498.80 US$2,574,794
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
6,189 -12.9%
500.02
US$3,094,609
6,189 -12.9% 500.02 US$3,094,609
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
7,395 -13.3%
500.69
US$3,702,626
7,395 -13.3% 500.69 US$3,702,626
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
5,002 -8.3%
502.15
US$2,511,757
5,002 -8.3% 502.15 US$2,511,757
2026-02-05 2026-02-03 S Sale

CEO

Executive Director
14,716 -19.6%
502.95
US$7,401,386
14,716 -19.6% 502.95 US$7,401,386
2026-02-05 2026-02-03 S Sale

EVP and Chief Clinical Officer

Officer
1,500 -4.8%
498.09
US$747,135
1,500 -4.8% 498.09 US$747,135
2026-02-03 2026-02-03 PrS Proposed sale

OFFICER

Officer
1,500
498.09
US$747,135
1,500 498.09 US$747,135
2026-02-03 2026-02-03 PrS Proposed sale

President, Chief Executive Officer & Director

Executive Director
42,877
501.04
US$21,483,274
42,877 501.04 US$21,483,274
2025-11-05 2025-11-05 PrS Proposed sale

OFFICER

Officer
3,892
473.79
US$1,843,991
3,892 473.79 US$1,843,991
2025-11-05 2025-11-05 S Sale

EVP & Chief Legal & Admin Off.

Officer
3,892 -52.7%
473.79
US$1,843,991
3,892 -52.7% 473.79 US$1,843,991
2025-09-08 2025-09-08 PrS Proposed sale

Officer

Officer
3,836
418.84
US$1,606,670
3,836 418.84 US$1,606,670
2025-09-08 2025-09-08 PlS Planned sale

EVP and Chief Clinical Officer

Officer
3,836 -10.9%
418.84
US$1,606,670
3,836 -10.9% 418.84 US$1,606,670
2025-05-15 2025-05-13 S Sale

EVP and COO

Officer
15,698 -55.4%
369.32
US$5,797,661
15,698 -55.4% 369.32 US$5,797,661
2025-05-13 2025-05-13 PrS Proposed sale

Officer

Officer
15,698
369.32
US$5,797,660
15,698 369.32 US$5,797,660
2025-02-18 2025-02-14 S Sale

SVP & Chief Human Res. Officer

Officer
5,378 -25.9%
322.31
US$1,733,362
5,378 -25.9% 322.31 US$1,733,362
2025-02-18 2025-02-14 S Sale

SVP & Chief Human Res. Officer

Officer
4,155 -16.7%
322.96
US$1,341,878
4,155 -16.7% 322.96 US$1,341,878
2025-02-14 2025-02-14 PrS Proposed sale

Officer

Officer
9,533
322.59
US$3,075,238
9,533 322.59 US$3,075,238
2025-02-11 2025-02-11 PrS Proposed sale

Former Officer

Officer
3,510
322.39
US$1,131,589
3,510 322.39 US$1,131,589
2025-01-31 2025-01-31 PrS Proposed sale

Former Officer

Officer
3,228
335.26
US$1,082,203
3,228 335.26 US$1,082,203
2024-11-18 2024-11-14 S Sale

SVP & Chief Ethics Officer

Officer
1,474 -13.5%
357.99
US$527,677
1,474 -13.5% 357.99 US$527,677
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
1,474
357.99
US$527,677
1,474 357.99 US$527,677
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
4,872
357.86
US$1,743,480
4,872 357.86 US$1,743,480
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
3,897
350.00
US$1,363,950
3,897 350.00 US$1,363,950
2024-11-14 2024-11-14 S Sale

Group President

Officer
2,900 -29.8%
353.00
US$1,023,700
2,900 -29.8% 353.00 US$1,023,700
2024-11-14 2024-11-14 PlS Planned sale

SVP-Internal Audit Services

Officer
3,897 -6.9%
350.00
US$1,363,950
3,897 -6.9% 350.00 US$1,363,950
2024-09-12 2024-09-12 PrS Proposed sale

Officer

Officer
8,358
385.42
US$3,221,340
8,358 385.42 US$3,221,340
2024-09-12 2024-09-12 PlS Planned sale

EVP and Chief Clinical Officer

Officer
8,358 -22.0%
385.42
US$3,221,340
8,358 -22.0% 385.42 US$3,221,340
2024-07-31 2024-07-31 PrS Proposed sale

Officer

Officer
2,987
363.51
US$1,085,804
2,987 363.51 US$1,085,804
2024-07-31 2024-07-31 S Sale

SVP & Chief Ethics Officer

Officer
2,987 -24.0%
363.51
US$1,085,804
2,987 -24.0% 363.51 US$1,085,804
2024-07-31 2024-07-29 S Sale

SVP & Chief Ethics Officer

Officer
1,864 -13.0%
359.92
US$670,891
1,864 -13.0% 359.92 US$670,891
2024-07-31 2024-07-29 S Sale

SVP - Mktg. & Communications

Officer
3,314 -48.6%
359.96
US$1,192,914
3,314 -48.6% 359.96 US$1,192,914
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
4,000
360.20
US$1,440,783
4,000 360.20 US$1,440,783
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
3,314
359.96
US$1,192,914
3,314 359.96 US$1,192,914
2024-07-29 2024-07-29 PrS Proposed sale

Officer

Officer
1,864
359.92
US$670,891
1,864 359.92 US$670,891
2024-07-29 2024-07-29 S Sale

SVP & Controller

Officer
4,000 -9.0%
360.20
US$1,440,782
4,000 -9.0% 360.20 US$1,440,782
2024-07-29 2024-07-25 S Sale

SVP-Payer Contracting & Align.

Officer
1,857 -9.5%
355.05
US$659,328
1,857 -9.5% 355.05 US$659,328
2024-07-25 2024-07-25 PrS Proposed sale

Officer

Officer
1,857
355.05
US$659,328
1,857 355.05 US$659,328
2024-05-20 2024-05-16 S Sale

SVP & Chief Ethics Officer

Officer
3,204 -25.3%
326.30
US$1,045,465
3,204 -25.3% 326.30 US$1,045,465
2024-05-16 2024-05-16 PrS Proposed sale

Officer

Officer
3,204
326.30
US$1,045,465
3,204 326.30 US$1,045,465
2024-05-17 2024-05-15 S Sale

SVP-Payer Contracting & Align.

Officer
1,863 -8.7%
326.18
US$607,673
1,863 -8.7% 326.18 US$607,673
2024-05-15 2024-05-15 PrS Proposed sale

Officer

Officer
1,863
326.18
US$607,673
1,863 326.18 US$607,673
2024-05-13 2024-05-09 S Sale

SVP-Government Relations

Officer
1,650 -24.1%
313.00
US$516,450
1,650 -24.1% 313.00 US$516,450
2024-05-13 2024-05-09 S Sale

EVP and Chief Clinical Officer

Officer
6,311 -17.6%
316.88
US$1,999,825
6,311 -17.6% 316.88 US$1,999,825
2024-05-09 2024-05-09 PrS Proposed sale

Officer

Officer
1,650
313.00
US$516,450
1,650 313.00 US$516,450
2024-05-09 2024-05-09 PrS Proposed sale

Officer

Officer
6,311
316.88
US$1,999,824
6,311 316.88 US$1,999,824
2024-05-07 2024-05-07 PrS Proposed sale

Former Officer

Officer
15,000
311.36
US$4,670,373
15,000 311.36 US$4,670,373
2024-05-08 2024-05-06 PlS Planned sale

EVP and Chief Clinical Officer

Officer
1,600 -4.5%
309.00
US$494,400
1,600 -4.5% 309.00 US$494,400
2024-05-06 2024-05-06 PrS Proposed sale

Officer

Officer
1,600
309.00
US$494,400
1,600 309.00 US$494,400
2024-05-06 2024-05-03 S Sale

SVP-Payer Contracting & Align.

Officer
890 -4.0%
312.00
US$277,680
890 -4.0% 312.00 US$277,680
2024-05-06 2024-05-02 S Sale

SVP-Payer Contracting & Align.

Officer
973 -4.2%
312.00
US$303,576
973 -4.2% 312.00 US$303,576
2024-05-02 2024-05-02 PrS Proposed sale

Officer

Officer
1,863
312.00
US$581,256
1,863 312.00 US$581,256
2024-03-20 2024-03-20 PrS Proposed sale

Officer

Officer
876
330.25
US$289,299
876 330.25 US$289,299
2024-03-20 2024-03-20 PlS Planned sale

SVP and CIO

Officer
876 -35.7%
330.25
US$289,299
876 -35.7% 330.25 US$289,299
2024-03-20 2024-03-18 PlS Planned sale

SVP and CIO

Officer
344 -12.3%
321.97
US$110,758
344 -12.3% 321.97 US$110,758
2024-03-18 2024-03-18 PrS Proposed sale

Officer

Officer
344
321.97
US$110,758
344 321.97 US$110,758
2024-02-13 2024-02-09 S Sale

SVP & Chief Ethics Officer

Officer
4,262 -29.4%
306.21
US$1,305,074
4,262 -29.4% 306.21 US$1,305,074
2024-02-09 2024-02-09 PrS Proposed sale

Officer

Officer
4,262
306.21
US$1,305,074
4,262 306.21 US$1,305,074
2024-02-06 2024-02-06 PrS Proposed sale

Officer

Officer
6,000
310.63
US$1,863,780
6,000 310.63 US$1,863,780
2024-02-06 2024-02-06 S Sale

CFO and EVP

Officer
6,000 -41.5%
310.63
US$1,863,780
6,000 -41.5% 310.63 US$1,863,780
2024-02-07 2024-02-05 S Sale

SVP & Controller

Officer
4,000 -9.7%
312.42
US$1,249,680
4,000 -9.7% 312.42 US$1,249,680
2024-02-06 2024-02-05 S Sale

SVP & Chief Nurse Executive

Officer
1,645 -17.7%
312.00
US$513,240
1,645 -17.7% 312.00 US$513,240
2024-02-05 2024-02-05 PrS Proposed sale

Officer

Officer
4,000
312.42
US$1,249,680
4,000 312.42 US$1,249,680
2024-02-05 2024-02-05 PrS Proposed sale

Officer

Officer
1,645
312.00
US$513,240
1,645 312.00 US$513,240
2024-02-06 2024-02-02 PlS Planned sale

SVP and CIO

Officer
652 -69.2%
312.04
US$203,451
652 -69.2% 312.04 US$203,451
2024-02-02 2024-02-02 PrS Proposed sale

Officer

Officer
652
312.04
US$203,451
652 312.04 US$203,451
2024-02-02 2024-01-31 PlS Planned sale

EVP and Chief Clinical Officer

Officer
3,200 -11.4%
306.79
US$981,734
3,200 -11.4% 306.79 US$981,734
2024-02-02 2024-01-31 S Sale

SVP-Payer Contracting & Align.

Officer
3,861 -19.5%
307.00
US$1,185,327
3,861 -19.5% 307.00 US$1,185,327